Startups
Biotechnology / Federal government

PGDx test gets ‘Breakthrough Device’ designation

A liquid biopsy test made by the Baltimore-based company received the status.

Baltimore-based Personal Genome Diagnostics (PGDx) recently received a designation from federal regulators that’s designed to help allow patients to get quicker access to new devices.
The U.S. Food and Drug Administration’s Center for Devices and Radiological Health granted a “Breakthrough Device” designation for one of the Johns Hopkins spinout’s new kinds of cancer tests, which combine genomic analysis and the use of algorithms to analyze data.
Known as PGDx elio plasma resolve, the test is a liquid biopsy, a new form of genomic testing which allows a sample to be taken for analysis without requiring surgery. Along with the materials to run a test, the product includes a server and software for data analysis, said PGDx Senior Marketing Manager KC McGrath.
The Breakthrough Device designation is designed to expedite regulatory approval of a medical device that provides a more effective treatment or diagnoses for a debilitating disease or condition. The PGDx was selected based on results that showed it may help patients who cannot provide tissue samples. A feature of the test could also help select patients for certain therapies.
If approved, the company indicated it could be the first liquid biopsy test that can be “kitted” and run in laboratories.
Being granted the status “shows there is an unmet clinical need that PGDx elio plasma resolve can help address, and we’re excited about the opportunity to impact more patients globally by enabling this test to be run locally,” McGrath said.
Canton-based PGDx closed on $75 million in Series B funding earlier this year, and opened a second location in Brewers Hill.

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

How to encourage more healthcare entrepreneurship (and why that matters)

Welcome to Camp Apple Intelligence

Find out what type of heat wave you’re really in for with NOAA’s HeatRisk dashboard

Baltimore Money Moves: Howard County cyber company lands $150M Series D

Technically Media